Welcome to our dedicated page for Cannae Holdings SEC filings (Ticker: CNNE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cannae Holdings, Inc. (NYSE: CNNE), a Nevada-incorporated holding company that acquires and actively manages interests in operating businesses. Through these filings, readers can review how Cannae reports material events, portfolio transactions, governance changes, and financial information in its capacity as a public company.
Cannae’s current reports on Form 8-K illustrate several key aspects of its regulatory history. The company has used Form 8-K to disclose the completion of the disposition of all of its equity interests in Dun & Bradstreet Holdings, Inc., including the aggregate cash proceeds it received and the fact that it no longer holds any ownership interest in that company. Other 8-K filings cover the announcement of quarterly financial results and the furnishing of related press releases and letters to shareholders, which discuss results of operations and financial condition.
Filings also document important governance developments. Cannae reported shareholder approval of an amendment to its Articles of Incorporation to declassify its board of directors and the subsequent filing of Amended and Restated Articles of Incorporation and Amended and Restated Bylaws to implement the declassification. Another 8-K details the matters submitted to a vote at the 2025 annual meeting of shareholders, including director elections, an advisory vote on executive compensation, ratification of the independent auditor, approval of the declassification amendment, and a shareholder proposal.
By reviewing Cannae’s Forms 8-K, along with its annual and quarterly reports and proxy statements referenced in those filings, investors can see how the company describes its permanent capital model, portfolio actions, capital allocation decisions, and governance structure in official regulatory documents. AI-powered tools on this page can help summarize lengthy filings, highlight key items such as major asset dispositions, charter and bylaw amendments, and shareholder voting results, and make it easier to navigate CNNE’s SEC disclosure history.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 as an “A” code transaction, reflecting a grant priced at $0. Following this award, the reporting person beneficially owned 207,437 shares directly.
The grant is described as restricted stock that will vest in three equal annual installments beginning November 12, 2026. The filing also lists 0 shares held indirectly via the Frank and Marisa Martire 2012 Florida Trust after the reported transaction.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a restricted stock grant. Following the transaction, the director’s beneficial ownership stands at 28,818 shares.
The award vests in three equal annual installments beginning November 12, 2026, aligning compensation with longer-term service. This filing documents the grant and updated holdings; it does not indicate any open-market purchase or sale.
Cannae Holdings (CNNE) reported an insider equity award. A director received a grant of 7,818 shares of restricted stock on November 12, 2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.
Following the grant, the director beneficially owns 34,733 shares directly. Indirect holdings include 1,942 shares through Holland III Family LP and 8,058 shares through the Malcolm Holland IRA.
Cannae Holdings, Inc. (CNNE) reported an insider equity grant. A director acquired 7,818 shares of common stock on 11/12/2025 at $0, coded as an acquisition (A).
The filing notes this was a grant of restricted stock that vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 66,853 shares, held directly.
Cannae Holdings (CNNE): Form 4 insider equity grant. A director received 15,635 shares of common stock as a restricted stock award on 11/12/2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.
Following the transaction, beneficial ownership is reported as 1,008,235 shares direct and indirect holdings of 748,299 via Folco Development Corp., 236,011 via Foley Family Charitable Foundation, and 2,849,803 via Foley Family Enterprises LLC.
Cannae Holdings (CNNE) reported a director equity grant on a Form 4. On 11/12/2025, the reporting person acquired 23,453 shares of common stock at $0, identified as a grant of restricted stock.
Following the transaction, the director beneficially owns 62,356 shares, held directly. The grant vests in three equal annual installments beginning November 12, 2026.
Cannae Holdings (CNNE): Schedule 13G/A Amendment No. 1 filed by Newtyn Management, LLC. The filer reports beneficial ownership of 3,411,827 shares of common stock, representing 6.1% of the class as of September 30, 2025. The percentage is based on 56,014,815 shares outstanding as of August 8, 2025.
Holdings are through two funds managed by Newtyn: Newtyn TE Partners, LP with 2,120,341 shares and Newtyn Partners, LP with 1,291,486 shares. Newtyn, an investment adviser, reports sole voting and sole dispositive power over all 3,411,827 shares, with no shared power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control, consistent with a passive Schedule 13G filing.
Carronade Capital Master, LP and its affiliates are running a proxy contest at Cannae Holdings, Inc., seeking to elect four director nominees at the company’s 2025 annual shareholder meeting using a GOLD universal proxy card. Carronade has supplemented its definitive proxy statement and is actively campaigning through social media and a dedicated website. In a campaign video, Carronade criticizes Cannae’s share-price performance versus peers and asserts that Cannae’s leadership and board decisions have been costly for shareholders, urging investors to "put shareholders first" and vote GOLD for its slate.
Cannae Holdings, Inc. is the target of a proxy solicitation by Carronade Capital Master, LP seeking election of four director nominees at the Company’s 2025 annual meeting.
Carronade, which beneficially owns approximately 3.2 million shares, filed a definitive proxy statement and a supplement and released an investor presentation and press release on November 10, 2025 outlining governance and value-creation arguments. Shareholders must vote by 11:59 pm Pacific Time on December 11, 2025 for votes to be counted; the Annual Meeting is scheduled for December 12, 2025.
Cannae Holdings (CNNE) reported a wider quarterly loss as affiliate results weighed on Q3 2025. Total operating revenues were $106.9 million versus $113.9 million a year ago, driven by restaurant revenue of $94.6 million and other operating revenue of $12.3 million. Operating loss improved to $13.2 million from $18.1 million, but equity in losses of unconsolidated affiliates of $57.5 million, primarily from Alight, led to a net loss attributable to common shareholders of $68.4 million, or $1.25 per share, compared with a $13.6 million loss last year.
Cannae closed the Dun & Bradstreet disposition on August 26, 2025, receiving aggregate cash proceeds of $540.3 million for its remaining 59,048,691 shares after a prior sale of 10.0 million shares for $89.5 million. Cash and cash equivalents rose to $233.8 million from $131.5 at year-end, aided by $629.8 million of D&B share sale proceeds year-to-date. The company repurchased 9,705,074 shares for $189.8 million under the 2023 program in the first nine months and 2,295,463 shares for $42.1 million under the 2022 program; additional repurchases occurred after quarter-end. Shares outstanding were 51,578,136 at September 30, 2025 and 49,285,406 as of November 7, 2025.